Loading clinical trials...

AQT90 FLEX NTproBNP2 Test Kit Matrix Comparison and Sample Stability Verification Study | Clinical Trials | Clareo Health

COMPLETED

AQT90 FLEX NTproBNP2 Test Kit Matrix Comparison and Sample Stability Verification Study

NCT06905392•Radiometer Medical ApS

View on ClinicalTrials.gov

Summary

The purpose of this study is to establish the correlation between sample matrices, and to determine the sample stability for the NTproBNP2 Test Kit on the AQT90 FLEX analyzer.

Eligibility

Age

18 - No limit years

Sex

ALL

Healthy Volunteers

Inclusion Criteria

•Subjects must be able to understand given information and demonstrate willingness and ability to voluntarily give a signed, valid written informed consent to participate in the study.
•Subjects must be 18 years of age or older.
•Subjects with expected NT-proBNP concentrations within the measuring range of NTproBNP2 Test Kit.

Exclusion Criteria

•Subjects known to be pregnant or breast-feeding.
•Subjects previously enrolled in the study.
•Subject, who has withdrawn consent.

Locations (5)

Hennepin Healthcare (Research Institute/ Minneapolis Medical Research Foundation)

Minneapolis, Minnesota, United States

Hospital Universitario Virgen de la Arrixaca

Murcia, Spain

Clinica Universidad de Navarra

Pamplona, Spain

Hospital Clinico Universitario de Santiago Compostela

Santiago de Compostela, Spain

Servicio Andaluz de Salud (SAS) - Hospital San Juan de la Cruz

Ùbeda, Spain

Key Dates

Start Date

May 15, 2025

Primary Completion Date

January 2, 2026

Completion Date

January 2, 2026

Last Updated

February 17, 2026

Enrollment

154

ACTUAL participants

Conditions

Diagnostic Tests